Charles Sherwood
Net worth: 67 477 $ as of 29/06/2026
Net worth: 67 477 $ as of 29/06/2026
Charles Sherwood is currently Director at Vedanta Biosciences, Inc. and COO, Secretary & General Counsel at PureTech Health Plc since 2021.
Formerly, Mr. Sherwood was Vice President-Legal Counsel at Anika Therapeutics, Inc. Education includes graduate studies at Vanderbilt University and undergraduate studies at Middlebury College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PURETECH HEALTH PLC 0.02% | 13/07/2026 | 37,001 ( 0.02% ) | 67 477 $ | 29/06/2026 |
| Companies | Position | Start |
|---|---|---|
| PURETECH HEALTH PLC | Chief Operating Officer | 31/07/2021 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | General Counsel | 31/07/2021 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
PureTech Health Plc
PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Select your edition
All financial news and data tailored to specific country editions